SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-026834
Filing Date
2019-05-16
Accepted
2019-05-16 16:08:10
Documents
3
Effectiveness Date
2019-05-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv521810-defa14a.htm DEFA14A 20215
2 GRAPHIC tv521669_prycrd3.jpg GRAPHIC 807150
3 GRAPHIC tv521669_prycrd4.jpg GRAPHIC 461416
  Complete submission text file 0001144204-19-026834.txt   1768269
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26770 | Film No.: 19832296
SIC: 2836 Biological Products, (No Diagnostic Substances)